Consensus Cerence Inc.

Equities

CRNC

US1567271093

Real-time Estimate Cboe BZX Other stock markets 01:24:41 2024-05-14 pm EDT			5-day change	1st Jan Change
5.07 ^USD	-0.59%		-43.31%	-72.84%

May. 10	Baird Adjusts Cerence Price Target to $8 From $15, Maintains Neutral Rating	MT
May. 10	Wedbush Adjusts Cerence's Price Target to $9 From $21, Keeps Neutral Rating	MT

Evolution of the average Target Price on Cerence Inc.

Price target over the last 5 years

History of analyst recommendation changes

8d20f8bde589b00ddc071b7.9mUnkeCnFDj7woxtT-0K93gakgjQgEzgSMnRY0cH3uI.pVVt5IrxJQ2pl_kHfolzmQxM5lyo2n_NKZyCPDFCn9CBLmP4t-liCIOTzQ~0602ade1ea0b88309af104ac245b4a32

Analyst Recommendations on Cerence Inc.

Baird Adjusts Cerence Price Target to $8 From $15, Maintains Neutral Rating	May. 10	MT
Wedbush Adjusts Cerence's Price Target to $9 From $21, Keeps Neutral Rating	May. 10	MT
Wells Fargo Downgrades Cerence to Equalweight From Overweight, Price Target at $6.50	May. 10	MT
Baird Adjusts Price Target on Cerence to $15 From $17, Maintains Neutral Rating	Apr. 17	MT
Wedbush Raises Cerence's Price Target to $21 From $19 After Higher-Than-Expected Fiscal Q1 Results, Keeps Neutral Rating	Feb. 07	MT
Craig-Hallum Downgrades Cerence to Hold From Buy, Price Target is $22	Feb. 07	MT
North American Morning Briefing : Rate Doubts Keep -2-	Feb. 06	DJ
Goldman Sachs Cuts Price Target on Cerence to $19 From $28 Amid Lower Outlook; Maintains Neutral Rating	Nov. 29	MT
Goldman Sachs Cuts Price Target on Cerence to $19 From $28 Amid Cut to Multi-Year Outlook, Lower Peer Multiples; Neutral Rating Kept	Nov. 29	MT
Wells Fargo Cuts Cerence's Price Target to $25 From $32, Maintains Overweight Rating	Nov. 28	MT
Needham Adjusts Cerence's Price Target to $23 From $34, Keeps Buy Rating	Nov. 28	MT
Wedbush Cuts Cerence's PT to $19 From $31 on Lower Multiple, Says Large Legacy Contract Write-Down to Overshadow Fiscal Year 2024 Guidance; Keeps Neutral Rating	Nov. 28	MT
Wedbush Raises Cerence's Price Target to $31 From $26 After Higher-Than-Expected Fiscal Q3 Results, Keeps Neutral Rating	23-08-09	MT
Wedbush Cuts Cerence's Price Target to $26 From $32, Keeps Neutral Rating	23-05-11	MT
Goldman Sachs Adjusts Price Target on Cerence to $28 From $31, Maintains Neutral Rating	23-05-10	MT
Wedbush Raises Cerence's Price Target to $32 From $25 After Above-Street Fiscal Q1 Results, Keeps Neutral Rating	23-02-10	MT
Goldman Sachs Adjusts Price Target on Cerence to $31 From $19, Maintains Neutral Rating	23-02-09	MT
Baird Adjusts Price Target on Cerence to $30 From $23, Maintains Neutral Rating	23-02-09	MT
Wells Fargo Adjusts Price Target on Cerence to $32 From $25, Maintains Overweight Rating	23-02-09	MT
Needham Adjusts Cerence's Price Target to $42 From $40, Keeps Buy Rating	23-02-09	MT
Craig-Hallum Upgrades Cerence to Buy From Hold, Price Target is $40	23-02-09	MT
Goldman Sachs Raises PT on Cerence to $19 From $17 as Q4 Results Were "Modestly Above Consensus", Maintains Neutral Rating	22-11-30	MT
Cowen Raises Price Target on Cerence to $35 From $32, Maintains Outperform Rating	22-11-30	MT
Jefferies Adjusts Price Target on Cerence to $20 From $25, Maintains Hold Rating	22-11-30	MT
Needham Adjusts Cerence's Price Target to $40 From $30, Keeps Buy Rating	22-11-30	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

5.1 USD

Average target price

8.214 USD

Spread / Average Target

+61.06%

High Price Target

12 USD

Spread / Highest target

+135.29%

Low Price Target

6 USD

Spread / Lowest Target

+17.65%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Cerence Inc.

Wells Fargo Securities
Wedbush
Baird
Craig-Hallum
Goldman Sachs
Needham & Co.
Jefferies & Co.
Cowen
RBC Capital Markets
Berenberg Bank
Raymond James
Evercore ISI

Ratings for Cerence Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar